{"id":10839,"date":"2025-09-23T22:19:31","date_gmt":"2025-09-23T22:19:31","guid":{"rendered":"https:\/\/cannabisindustryjournal.com\/?post_type=feature_article&amp;p=37451"},"modified":"2025-09-23T22:19:31","modified_gmt":"2025-09-23T22:19:31","slug":"inside-red-light-hollands-plan-to-bring-psilocybin-products-to-the-global-market","status":"publish","type":"post","link":"https:\/\/cannitrol.com\/blog\/inside-red-light-hollands-plan-to-bring-psilocybin-products-to-the-global-market\/","title":{"rendered":"Inside Red Light Holland\u2019s Plan to Bring Psilocybin Products to the Global\u00a0Market"},"content":{"rendered":"<div id=\"wp_fb_like_button\" style=\"margin:5px 0 5px 5px;float:right;height:100px;\"><script src=\"http:\/\/connect.facebook.net\/en_US\/all.js#xfbml=1\"><\/script><fb:like href=\"https:\/\/cannitrol.com\/blog\/inside-red-light-hollands-plan-to-bring-psilocybin-products-to-the-global-market\/\" send=\"true\" layout=\"standard\" width=\"450\" show_faces=\"false\" font=\"arial\" action=\"like\" colorscheme=\"light\"><\/fb:like><\/div><p><span data-preserver-spaces=\"true\">Red Light Holland (CSE: TRIP) has established its foundation in the Netherlands, where <img loading=\"lazy\" class=\"wp-image-37440 alignright\" src=\"https:\/\/cannitrol.com\/blog\/wp-content\/uploads\/2025\/09\/inside-red-light-hollands-plan-to-bring-psilocybin-products-to-the-global-market.jpg\" alt=\"\" width=\"199\" height=\"168\" \/><span data-preserver-spaces=\"true\">psilocybin<\/span> <em>truffles,<\/em> <span data-preserver-spaces=\"true\">the underground sclerotia of psilocybin mushrooms, are legally permitted for cultivation and sale. The above-ground mushroom is prohibited, but the truffle is treated differently under Dutch law, despite delivering the same psychoactive effects.<\/span><\/span><\/p>\n<blockquote>\n<p><span data-preserver-spaces=\"true\">\u201cIt\u2019s really the same thing, with the same effects,\u201d says CEO Todd Shapiro, \u201cbut because it forms underground, it can be sold in compliance with Dutch law.\u201d<\/span><\/p>\n<\/blockquote>\n<p><span data-preserver-spaces=\"true\">From its cultivation facility, RLH distributes truffles through a wholesale partnership to over 150 wellness shops under its brands<\/span> <em><span data-preserver-spaces=\"true\">iMicrodose<\/span><\/em> <span data-preserver-spaces=\"true\">and<\/span> <em><span data-preserver-spaces=\"true\">Maka<\/span><\/em><span data-preserver-spaces=\"true\">. \u201cWe like to think of them as wellness shops rather than smart shops, like they are referred to in Holland,\u201d Shapiro explains, underscoring the company\u2019s emphasis on education, QR-code-based information, and community engagement. While regulations prevent RLH from turning truffles into edibles such as gummies or chocolates, its vacuum-sealed, raw truffles have become a steady revenue stream. \u201cThey\u2019re a bit walnut-y,\u201d Shapiro notes, \u201cbut they sell well and people rarely complain.\u201d<\/span><\/p>\n<p><strong><span data-preserver-spaces=\"true\">Canada: Positioning for a Regulated Future\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/span><\/strong><span data-preserver-spaces=\"true\">In Canada, RLH is preparing for the potential regulatory shift that could pave the way for the legalization of psilocybin products. The company has already developed psilocybin gummy formulations, but for now, it only sells them as functional mushroom products that don\u2019t contain psilocybin. This approach not only helps build brand recognition, but it also keeps the company R&amp;D-ready, allowing it to move quickly if Health Canada establishes a legal framework for psilocybin.<\/span><\/p>\n<p><strong><span data-preserver-spaces=\"true\">United States: Research Partnerships for Validation\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/span><\/strong> <span data-preserver-spaces=\"true\">South of the border, RLH has partnered with Irvine Labs, a DEA-registered laboratory in California. The lab is testing RLH\u2019s truffles, imported from the Netherlands, to confirm potency, safety, and pharmacological value. The partnership is central to RLH\u2019s long-term vision of formulating psilocybin capsules tailored to various needs, including microdosing, therapeutic use, and wellness.<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">Shapiro frames the multi-pronged approach as deliberate groundwork for the future. \u201cThe Netherlands gives us a legal, revenue-generating business today. Canada positions us for tomorrow. And in the U.S., we\u2019re laying the foundation with science so that when the regulatory environment changes, we\u2019ll be ready.\u201d<\/span><\/p>\n<p><strong><span data-preserver-spaces=\"true\">Research &amp; Consumer Insights\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/span><\/strong> <span data-preserver-spaces=\"true\">In addition to building commercial distribution, Red Light Holland is investing in research that could help shape future regulations. Through its<\/span> <em><span data-preserver-spaces=\"true\">iMicrodose<\/span><\/em> <span data-preserver-spaces=\"true\">app, the company collects voluntary, anonymized data from consumers in the Netherlands on how they are using psilocybin truffles, whether for trauma, pain management, recreation, or general wellness. Shapiro points to a substantial interest in using psilocybin to tame menopause symptoms from their data.<\/span><\/p>\n<blockquote>\n<p><span data-preserver-spaces=\"true\">\u201cWe ask our consumers if they\u2019d like to participate in the app and give us data on how they\u2019re using it,\u201d explains Shapiro.<\/span><\/p>\n<\/blockquote>\n<p><span data-preserver-spaces=\"true\">The data was analyzed in collaboration with Drug Science UK under the leadership of renowned neuroscientist Professor David Nutt, one of the most respected voices in psychedelic research and policy. The published study confirmed that RLH\u2019s data provided meaningful evidence of consumer benefit. \u201cA lot of it is anecdotal research, which is key research,\u201d says Shapiro. \u201cIt\u2019s almost like its own Phase 1.\u201d<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">The findings also carried a regulatory impact. RLH presented its consumer data to lawmakers in Oregon as they developed the state\u2019s psilocybin program, contributing to the inclusion of microdosing language in the final bill. \u201cThis was a huge win for the company,\u201d Shapiro says. \u201cIt adds credibility, validation, and shows how we can responsibly influence policy through science-backed data.\u201d<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">For RLH, consumer research serves a dual purpose: it provides a self-regulatory framework for the safe distribution of products today, and it informs the company\u2019s plans for future formulations as regulations evolve.<\/span><\/p>\n<p><strong>Standardization &amp; Medical Pathways\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/strong><span data-preserver-spaces=\"true\">Red Light Holland is also working behind the scenes to prepare psilocybin for the medical market. The company has partnered with labs in both Canada and the U.S. to analyze and standardize its products, laying the groundwork for future pharmaceutical-style formulations.<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">In Canada, RLH has collaborated with Seacrest Laboratories in Montreal, securing multiple permits for the import of psilocybin<\/span> <span data-preserver-spaces=\"true\">from Health Canada<\/span><span data-preserver-spaces=\"true\">.<\/span> <span data-preserver-spaces=\"true\">These projects have produced certificates of analysis (COAs) to understand psilocybin content better and explore standardized dosing formats. \u201cWe\u2019re learning about the standardization of our product,\u201d says Shapiro, \u201cwhether that eventually becomes ground into powder form or an extract. The end goal is to move toward a consistent, pill-like product for microdosing.\u201d<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">In the U.S., RLH works with Irvine Labs in California, a rare FDA-approved, DEA-compliant facility, to advance similar objectives. The partnership underscores RLH\u2019s long-term ambition: validating its Dutch truffles as a source for medical-grade psilocybin products that could one day be distributed under compassionate care or special access programs.<\/span><\/p>\n<blockquote>\n<p><span data-preserver-spaces=\"true\">\u201cIt\u2019s a slow path,\u201d Shapiro admits. \u201cNo one would normally start a business that they could only sell in about one percent of the world. But if you want to be an outlier versus an outlaw, you take the careful approach by generating sustainable revenue in Holland while advancing science and regulations in North America.\u201d<\/span><\/p>\n<\/blockquote>\n<p><strong><span data-preserver-spaces=\"true\">Slow and Steady\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/span><\/strong> <span data-preserver-spaces=\"true\">While regulatory doors are starting to crack open in places like Germany, Australia, New Zealand, and the Czech Republic, RLH isn\u2019t rushing in. Shapiro is careful to point out that the company has no interest in repeating the mistakes of many cannabis operators who built massive facilities before the market was ready, only to burn through cash and collapse in oversaturated conditions. Instead, RLH is pacing itself, positioning products, standardizing formulations, and preparing for the moment commercialization becomes viable.<\/span><\/p>\n<blockquote>\n<p><span data-preserver-spaces=\"true\">\u201cIt\u2019s frustrating for some investors who want instant results,\u201d Shapiro admits, \u201cbut the reality is we can only sell in one percent of the world right now. We\u2019d run out of money if we tried to scale too fast. Every move has to be deliberate.\u201d<\/span><\/p>\n<\/blockquote>\n<p><span data-preserver-spaces=\"true\">For RLH, the mission remains steady: take psilocybin from the underground to the mainstream. Until regulations evolve, the company is committed to cautious progress, ensuring it will be ready to deliver once legalization expands.<\/span><\/p>\n<p><strong><span data-preserver-spaces=\"true\">Market Readiness\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/span><\/strong><span data-preserver-spaces=\"true\">To help normalize psilocybin, RLH has leveraged functional mushrooms with its<img loading=\"lazy\" class=\"size-medium wp-image-37447 alignright\" src=\"https:\/\/cannabisindustryjournal.com\/wp-content\/uploads\/2025\/09\/Happy-Caps-200x200.webp\" alt=\"\" width=\"200\" height=\"200\" \/> Happy Caps grow kits and mushroom gummies to establish brand awareness. Happy Caps started as homegrow kits for lion\u2019s mane, shiitake, and oyster mushrooms, products that ended up on the shelves of Costco and other major Canadian retailers. The idea is simple: just as Canada allowed adults to grow cannabis at home after legalization, psilocybin might one day follow a similar path. If that happens, RLH will already be positioned with both the distribution channels and consumer familiarity to shift from lion\u2019s mane to psilocybin.<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">More recently, RLH launched mushroom gummies in Canada made with a lion\u2019s<img loading=\"lazy\" class=\"size-medium wp-image-37448 alignright\" src=\"https:\/\/cannabisindustryjournal.com\/wp-content\/uploads\/2025\/09\/Happy-Caps-gummies-200x200.webp\" alt=\"\" width=\"200\" height=\"200\" \/> mane and shiitake blend. These gummies carry a Health Canada\u2013approved NPN number, which allows the company to make validated health claims, such as immune-boosting and antioxidant properties that most competitors cannot legally advertise. Shapiro says this not only sets RLH apart in the crowded functional mushroom category, but also provides a ready-made blueprint for psilocybin gummies once regulations allow. \u201cIt\u2019s a much easier way to consume than chewing on a raw truffle,\u201d he explains. In other words, today\u2019s Happy Caps gummies are tomorrow\u2019s psilocybin edibles.<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">In parallel, RLH is deepening its scientific foundation through a partnership with Irvine Labs. The company has already imported truffle samples for testing, focusing on potency, shelf-life stability, and consistency\u2014critical steps in moving psilocybin from a naturally variable product to a standardized medicine. \u201cIf you\u2019re microdosing for medical reasons, you want to be sure each dose delivers the same effect,\u201d Shapiro explains.<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">That requires rigorous testing under pharmaceutical standards, much like cannabis research has revealed the complexities of the entourage effect.<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">Shelf stability has emerged as one of the biggest challenges. Like fresh produce, truffles degrade quickly if not kept under controlled conditions.<\/span> <span data-preserver-spaces=\"true\">For RLH, understanding how to preserve potency over time is<\/span> <span data-preserver-spaces=\"true\">key to<\/span> <span data-preserver-spaces=\"true\">developing future formulations, whether in pill or<\/span> <span data-preserver-spaces=\"true\">extraction<\/span> <span data-preserver-spaces=\"true\">form.<\/span> <span data-preserver-spaces=\"true\">\u201cConsistency is always the goal when it comes to drug discovery,\u201d Shapiro notes.<\/span><\/p>\n<p><strong><span data-preserver-spaces=\"true\">Strategic Growth Through M&amp;A\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/span><\/strong> <span>Beyond consumer products and R&amp;D, RLH is also exploring mergers and acquisitions as a path to scale. Shapiro says the focus is on acquiring brands with strong recognition and the potential to be cash flow positive, rather than companies burning capital. \u201cA great Instagram account and loyal customers can be half the battle,\u201d he notes. The idea is to consolidate products, share resources, and expand distribution while maintaining financial discipline.<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">Still, opportunities are scarce. After reviewing more than 40 companies over the past two years, Shapiro says nearly all were losing money. The demands of major retailers compound the challenge\u2014fulfilling large orders requires significant upfront inventory and the ability to survive long payment cycles, which can stretch 90 days or more.<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">While RLH has heard of pioneering efforts, such as Oregon\u2019s first psilocybin edibles, local ownership laws, and public company reporting requirements make direct entry into that market difficult. For now, the company continues to evaluate partnerships and acquisitions that align with its strategy, while supporting others that advance the industry. As Shapiro puts it, \u201cRising tides lift all boats.\u201d<\/span><\/p>\n<p><strong><span data-preserver-spaces=\"true\">Looking Ahead\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/span><\/strong> <span data-preserver-spaces=\"true\">Red Light Holland is narrowing its focus on CPG products, leveraging its experience in the Netherlands while preparing for a global market. While the company continues some cultivation, its strategy centers on creating standardized, science-backed psilocybin products that can reach more people and address the growing mental health crisis. \u201cWe\u2019re a psilocybin company at the end of the day,\u201d says Shapiro, \u201cfocused on products that can help people, responsibly and sustainably, while navigating complex regulations and building a foundation for future growth.\u201d By combining research, consumer insights, careful regulatory planning, and selective M&amp;A, RLH is positioning itself to take psilocybin from niche wellness shops to mainstream markets worldwide.<\/span><\/p>\n<div class=\"sharedaddy sd-sharing-enabled\">\n<div class=\"robots-nocontent sd-block sd-social sd-social-icon-text sd-sharing\">\n<h3 class=\"sd-title\">Share this:<\/h3>\n<\/p><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Red Light Holland (CSE: TRIP) has established its foundation in the Netherlands, where psilocybin truffles, the underground sclerotia of psilocybin mushrooms, are legally permitted for cultivation and sale. The above-ground mushroom is prohibited, but the truffle is treated differently under Dutch law, despite delivering the same psychoactive effects. \u201cIt\u2019s really the same thing, with the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[8459,5062,146,52,8509,8461,5179,8503,8770,1964,5334,2254,5763,8514,8771,184,9,8504,8554,10794,8472,10795,8520,1,3,8524,61,1736],"tags":[8481,5063,2724,2632,8535,8483,5181,8529,8780,4532,5350,4821,5771,8540,8781,2762,8530,8576,10796,8494,10797,8546,8550],"_links":{"self":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/posts\/10839"}],"collection":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/comments?post=10839"}],"version-history":[{"count":0,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/posts\/10839\/revisions"}],"wp:attachment":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/media?parent=10839"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/categories?post=10839"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/tags?post=10839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}